Methods | Randomisation done, description not given. Double blind trial. Preparations in neutral packaging. |
|
Participants | 100 women with trichomoniasis in Sweden. Most partners were treated. Exclusion criteria: concurrent infection with other pathogen found. |
|
Interventions | Nifuratel 200 mg by mouth 3 times a day for 7 days plus 250 mg intravaginally daily for 10 days, versus metronidazole 200 mg by mouth 3 times a day for 7 days plus 500 mg intravaginally daily for 10 days. | |
Outcomes | Parasitological and clinical cure. Side effects. | |
Notes | Diagnosis by smear and symptomology. Follow up 14 days after treatment (patients found positive receive another treatment with the same regimen and are examined again after 14 days). 12% loss to follow up in nifuratel group, 3% in metronidazole group. |